22nd May 2017 16:40
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Mr R G Connor | |||
b) | Position/status | President, Global Manufacturing & Supply | |||
c) | Initial notification/ amendment | Initial Notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882 | |||
b) | Nature of the transaction | The sale of 16,065 Ordinary Shares on 19 May 2017 at a price of £16.4227. | |||
c) | Price(s) and volume(s) |
| Price(s) | Volume(s) |
|
| £16.4227 | 16,065 |
| ||
|
|
|
| ||
d) | Aggregated information | n/a (single transaction) | |||
Aggregated volume Price |
| ||||
e) | Date of the transaction | 2017-05-19 | |||
f) | Place of the transaction
| London Stock Exchange (XLON) | |||
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Mrs D Connor | |||
b) | Position/status | PCA of Mr R G Connor (President, Global Manufacturing & Supply) | |||
c) | Initial notification/ amendment | Initial Notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
| |||
b) | Nature of the transaction | The sale of 7,435 Ordinary Shares on 19 May 2017 at a price of £16.4153. | |||
c) | Price(s) and volume(s) |
| Price(s) | Volume(s) |
|
| £16.4153 | 7,435 |
| ||
|
|
|
| ||
d) | Aggregated information | n/a (single transaction) | |||
Aggregated volume Price |
| ||||
e) | Date of the transaction | 2017-05-19 | |||
f) | Place of the transaction
| London Stock Exchange (XLON) | |||
Related Shares:
Glaxosmithkline